Avidity Biosciences Reports Second Quarter 2023 Financial Results and Recent Highlights

Go back to Avidity Biosciences Reports Second Quarter 2023 Financial Results and Recent Highlights

Prosensa Holding N.V. (RNA) Tops Q2 EPS by 13c

August 8, 2023 5:01 PM EDT

Prosensa Holding N.V. (NASDAQ: RNA) reported Q2 EPS of ($0.66), $0.13 better than the analyst estimate of ($0.79). Revenue for the quarter came in at $2.32 million versus the consensus estimate of $2.14 million.

For earnings history and earnings-related data on Prosensa Holding N.V. (RNA) click here.

... More